30
Participants
Start Date
June 30, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Long-acting bedtime insulin detemir (Levemir)
This group will receive Insulin detemir. Insulin detemir is given at bedtime aiming at a fasting plasma glucose between 80-100 mg/dl.
Insulin detemir and pre-meal insulin aspart.
This group will receive Insulin detemir plus aspart. The group will start with Insulin detemir at bedtime. Then in three months they will Insulin aspart before breakfast, lunch and dinner.
The University of Texas H.S.C. at San Antonio and the San Antonio Audie L. Murphy VA Hospital, San Antonio
Collaborators (1)
VA Office of Research and Development
FED
Novo Nordisk A/S
INDUSTRY
University of Florida
OTHER